Status: Recruiting
Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders
The investigators want to study the JAK-inhibitors and their impact on the immune system and evaluate the potential of a gene-therapeutic strategy
Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: prof. dr. Rik SchrijversUpdated: Dec 3, 2025Locations: 1
Eligibility criteria
Cases (A): adult patients presenting with a genetically confirmed or highly susp... [+1]
Children (< 18 years at time of recruitment) [+1]